Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer
Version of Record online: 24 APR 2008
Copyright © 2008 Wiley-Liss, Inc.
Volume 68, Issue 10, pages 1105–1115, 1 July 2008
How to Cite
Bertilaccio, M. T.S., Grioni, M., Sutherland, B. W., Degl'Innocenti, E., Freschi, M., Jachetti, E., Greenberg, N. M., Corti, A. and Bellone, M. (2008), Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer. Prostate, 68: 1105–1115. doi: 10.1002/pros.20775
- Issue online: 23 MAY 2008
- Version of Record online: 24 APR 2008
- Manuscript Accepted: 17 MAR 2008
- Manuscript Received: 21 NOV 2007
- Associazione Italiana per la Ricerca sul Cancro. Grant Numbers: 58/2003, 2005-2007
- Ministero dell'Università e della Ricerca. Grant Number: FIRB-RBIP06LCA9-005
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.